Founder Group receives Nasdaq delisting notice over share rule
Founder Group Limited (NASDAQ:FGL), a solar energy solutions provider, has received a delisting notice from Nasdaq because it no longer meets the minimum requirement of 500,000 publicly held shares. The company's stock has seen a significant decline, plunging 92.6% over the past year. Nasdaq has given Founder Group until April 3, 2026, to submit a plan to regain compliance, and the company intends to do so.
Founder Group receives Nasdaq delisting notice over share rule
Founder Group Limited (NASDAQ:FGL), a solar energy solutions provider, has received a Nasdaq delisting notice for failing to meet the minimum publicly held shares requirement (500,000 shares) for the Nasdaq Capital Market. The company's shares have significantly dropped, though InvestingPro suggests they might be undervalued despite financial health concerns. Founder Group has until April 3, 2026, to submit a compliance plan and recently issued Class B shares as incentive payments and secured a $16.07 million convertible note financing.
Public Policy Holding Company plans US IPO on NASDAQ
Public Policy Holding Company, a government relations and strategic communications firm, announced its intention to confidentially submit a Registration Statement on Form S-1 to the U.S. SEC for an initial public offering on the Nasdaq Stock Market. The IPO aims to broaden access to capital markets, enhance shareholder liquidity, and support long-term business objectives, while the company maintains its current listing on London's AIM market. The offering is subject to SEC review, market conditions, and Nasdaq approval.
Aspire Biopharma regains Nasdaq compliance requirements
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) has regained full compliance with Nasdaq's listing requirements, including the minimum stockholders’ equity and minimum bid price. Despite this, the company will be under a one-year "Panel Monitor" to ensure continued equity compliance. Recent developments also include filing a provisional patent for a sublingual meclizine formulation and a Series A Convertible Preferred Stock.
Medtech firm Lifeward consolidates shares 12-to-1 to stay on Nasdaq
Lifeward (Nasdaq: LFWD) announced a 1-for-12 reverse share split, effective February 24, 2026, to meet Nasdaq's minimum $1.00 bid-price listing requirement. This action will reduce outstanding shares from approximately 18.3 million to 1.5 million, while also increasing authorized share capital to 100 million shares. The market reacted negatively to the news, with the stock declining 9.62%, fitting a pattern of investor skepticism seen in a previous reverse split in 2024.
NusaTrip stock halted on Nasdaq, but its travel business continues
Society Pass (SOPA) and its subsidiary NusaTrip (NUTR) have addressed the ongoing Nasdaq trading suspension of NusaTrip's securities following inquiries from the SEC and Nasdaq. Despite the regulatory investigation and trading halt, the companies maintain that NusaTrip's daily travel operations remain normal and unaffected.
Where regulated capital flows in digital assets: inside DeFi's new DVIO index
DeFi Technologies will host a webinar on February 24, 2026, at 10:00 a.m. ET to introduce its new DEFT Valour Investment Opportunity (DVIO) Index. The webinar will feature Andrew Forson, President of DeFi and Chief Growth Officer at Valour, discussing how regulated capital is allocated in the digital asset market and how the index will inform future product development and market analytics. The DVIO Index is designed as an institutional-grade benchmark for regulated investor flows within decentralized finance.
MediciNova reports preliminary 2025 financial results in Tokyo filing
MediciNova (NASDAQ:MNOV) has filed preliminary, unaudited financial results for the 2025 fiscal year with the Tokyo Stock Exchange. The company also highlighted recent clinical progress, including the completion of patient enrollment for its Phase 2b/3 trial of MN-166 in amyotrophic lateral sclerosis (ALS).
20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time
20/20 BioLabs (Nasdaq: AIDX) will host a virtual investor webinar on February 26, 2026, to discuss its recent Nasdaq listing and the upcoming launch of its OneTest for Longevity™ blood test. CEO Jonathan Cohen will lead the session, which includes updates on the company's AI-powered multi-cancer early detection technology and upcoming corporate milestones.
Merger Vehicle Unbundles Shares and Warrants for Nasdaq Investors
M Evo Global Acquisition Corp II has unbundled its common stock and warrants, allowing them to trade independently on Nasdaq under the symbols MEVO and MEVOW, respectively. This action, following its $300 million IPO, provides investors with greater flexibility for targeted portfolio strategies. The SPAC is focused on finding a merger partner within the critical minerals sector.
Responsive Playbooks and the OPTZ Inflection
Stock Traders Daily provides a technical analysis of the Optimize Strategy Index ETF (OPTZ), highlighting a neutral near-term outlook against a strong long-term positive bias. The report outlines three distinct AI-generated institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—with an exceptional 14:0 risk-reward setup targeting a 4.2% gain.
Gemini Space Station Executives Depart Amid Investigation
Gemini Space Station (GEMI) announced the sudden departure of its COO, CFO, and Chief Legal Officer effective February 17, 2026, leading to a significant 12.9% drop in share price. Several law firms have launched investigations into potential securities fraud and misleading statements following the departures and a 25% workforce reduction. Analysts from Needham and Cantor Fitzgerald have downgraded the stock, citing leadership instability and a worsening crypto volume outlook.
How Trueshares Structured Outcome (may) Etf (MAYZ) Affects Rotational Strategy Timing
The Trueshares Structured Outcome (May) ETF (MAYZ) is currently showing neutral near and mid-term readings within a mid-channel oscillation pattern. Despite this neutrality, the ETF maintains a strong long-term positive bias with an exceptional 9.3:1 risk-reward setup targeting a 2.8% gain.
Agenus Presents Biomarker Data Demonstrating Survival Stratification in MSS mCRC and Other Immunologically Cold Tumors Treated with BOT+BAL
Agenus Inc. announced new translational data showing that its botensilimab (BOT) and balstilimab (BAL) combination therapy effectively treats "immunologically cold" tumors like MSS colorectal cancer. The research identifies that integrating blood-based inflammatory markers with tumor immune features provides a superior method for predicting patient survival outcomes compared to traditional biomarkers.
Product & Service Launches
This article highlights several new product and service launches in the financial sector. AllianceBernstein selected SimCorp One as its investment technology partner, iPipeline introduced an AI-driven platform for life, annuities, and wealth management, and STOXX collaborated with DWS on the US launch of the Xtrackers Europe Defense Technologies ETF. Additionally, Bloomberg expanded its futures-based index offerings with the launch of the Bloomberg ERIS Swap Futures Tracker Indices.
Guarantor: JPMorgan Chase & Co.
JPMorgan Chase Financial Company LLC is offering $463,000 in Auto Callable Dual Directional Barrier Notes linked to the performance of the iShares Expanded Tech-Software Sector ETF, the State Street Energy Select Sector SPDR ETF, and the Nasdaq-100 Index. These notes are fully and unconditionally guaranteed by JPMorgan Chase & Co. The structured investment is designed for investors seeking early exit potential at a premium or uncapped/capped exposure to the least performing underlying asset at maturity, with significant risks including the potential loss of principal.
21Shares Rings Nasdaq Bell for Dogecoin ETF Launch but Limited Adoption Raises Questions on Growth Potential
21Shares celebrated the launch of its Dogecoin ETF (TDOG) on Nasdaq, ringing the opening bell on February 17, 2026. While the ETF offers regulated and transparent access to Dogecoin, its modest assets under management raise questions about its growth potential compared to ETFs tracking larger cryptocurrencies like Bitcoin and Ethereum. The article highlights that despite the fanfare, Dogecoin's largely speculative and retail-oriented investor base, coupled with its inflationary supply, may limit TDOG's ability to attract significant institutional capital.
UGI October 16th Options Begin Trading
New options for UGI Corp. (UGI) with an October 16th expiration became available, offering potential opportunities for options sellers due to the significant time value remaining until expiration. The article highlights a specific $40.00 strike price call contract, which, if sold as a covered call, could yield a 5.26% total return if the stock is called away, or a 0.52% premium boost (0.80% annualized) if the option expires worthless. This analysis examines the potential returns and risks, including the probability of the option expiring worthless based on current analytical data.
October 16th Options Now Available For Diageo (DEO)
New options for Diageo plc (DEO) with an October 16th expiration date are now trading. This article analyzes specific put and call contracts, highlighting potential opportunities for investors such as selling a put contract at a $95.00 strike for a possible 8.74% return if it expires worthless, or a covered call at a $100.00 strike offering a 10.94% total return. The analysis also includes implied volatility and historical performance relative to these strike prices.
Global Economic Outlook: February 2026
This February 2026 report from S&P Global analyzes the global economic outlook, highlighting the impact of geopolitical uncertainty on markets despite resilient economic conditions suggested by PMI data. It details key changes in their forecast, including higher real GDP growth projections for the US, India, and the eurozone, leading to an increased global growth forecast of 2.9% for 2026. The report also addresses consumer price inflation expectations, noting projected moderations driven by oil prices and easing underlying pressures, and discusses factors influencing US dollar depreciation and Federal Reserve policy.
October 16th Options Now Available For Franklin Resources (BEN)
New options contracts for Franklin Resources (BEN) with an October 16th expiration are now available for trading. This offers opportunities for investors to potentially earn higher premiums due to the longer time until expiration. Specific put and call contracts at strike prices of $27.00 and $28.00, respectively, are highlighted for their potential returns through selling puts or covered calls.
October 16th Options Now Available For Xylem (XYL)
New options contracts for Xylem Inc (XYL) with an October 16th expiration date are now available, offering opportunities for option sellers to gain higher premiums due to the longer time until expiration. BNK Invest's YieldBoost formula highlights specific put and call contracts, demonstrating potential returns and strategies such as selling a cash-secured put or a covered call. These strategies could offer annualized returns of 8.07% for the put and 8.94% for the covered call, based on current market conditions and implied volatility data.
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
Nautilus Biotechnology (NASDAQ: NAUT) will participate in the TD Cowen 46th Annual Health Care Conference. Management is scheduled for a fireside chat on March 2, 2026, to discuss the company's single-molecule protein analysis platform and its mission to transform the field of proteomics.
Averin Capital prices $250 million IPO at $10 per unit
Averin Capital Acquisition Corp. has priced its $250 million initial public offering, consisting of 25 million units at $10 each. The special purpose acquisition company (SPAC), led by CEO David A. Berry, intends to target mergers within the technology and health industries and will trade on the NASDAQ under the ticker ACAAU.
Phoenix pool supplies retailer closes 80 locations amid major losses
Phoenix-based Leslie’s Inc. (Nasdaq: LESL) has shuttered 80 underperforming stores and a distribution center in Illinois following a comprehensive asset review. The pool and spa care retailer is attempting to overcome significant financial losses, with CEO Jason McDonell reporting that most closures occurred within a week of the review's announcement.
Strong Analyst Support and Funding Boost Cipher Mining Inc. (CIFR)’s Outlook
Cipher Mining Inc. (CIFR) recently received an "Overweight" rating and a $38 price target from Morgan Stanley, which views it as well-positioned for the pivot to data centers. The company’s subsidiary also secured $2 billion in senior secured notes to fund a high-performance computing data center in Texas and reimburse prior equity contributions. Cipher Mining is transitioning from Bitcoin mining to hybrid operations including AI-focused HPC infrastructure.
Cboe Global Markets Stock: Is Wall Street Sleeping on This Power Play?
Cboe Global Markets (CBOE) is presented as a potentially underrated "power play" in the financial market, with strong performance in options trading, index products like VIX, and market data. The article highlights Cboe's growing global derivatives and digital assets footprint, along with AI and tech investments, suggesting it's a solid long-term investment for those betting on continued growth in trading volumes and market complexity. Despite recent stock gains, analysts generally maintain positive ratings, viewing it as a resilient, high-quality exchange franchise rather than a speculative bubble.
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates
Intellia Therapeutics has announced it will host a conference call on February 26, 2026, at 8 a.m. ET to discuss its fourth quarter and full-year 2025 financial results. The clinical-stage gene editing company will also provide business updates regarding its CRISPR-based therapy platform.
New Better Home & Finance leaders get stock tied to 2030 goals
Better Home & Finance Holding Company has granted inducement awards to its new CFO, Loveen Advani, new COO, Barry Feierstein, and 22 other new employees. These awards include restricted stock units (RSUs) and performance-based RSUs, with the latter vesting upon the achievement of specific company stock price and revenue goals by December 31, 2030, and time-vesting criteria. The grants are part of an Inducement Incentive Plan designed to attract new talent and are in compliance with Nasdaq Listing Rule 5635(c)(4).
2 of Wall Street's Favorite Stocks with Promising Prospects and 1 That Underwhelm
This article analyzes three stocks that have captured Wall Street's attention, providing an independent assessment of their prospects. It identifies Taboola (TBLA) as a stock to sell due to declining margins and EPS, while recommending Limbach (LMB) and Nasdaq (NDAQ) as stocks to watch due to their strong financial performance and growth indicators. The author emphasizes looking beyond analyst headlines to focus on fundamental analysis.
Agroz receives Nasdaq notice on minimum bid price requirement
Agroz Inc. (NASDAQ:AGROZ) has received a deficiency letter from the Nasdaq Capital Market because its ordinary shares have traded below the required $1.00 minimum bid price for 30 consecutive business days. The company has 180 calendar days, until August 17, 2026, to regain compliance by having its shares close at or above $1.00 for at least ten consecutive business days. Failure to comply could lead to delisting proceedings, although an extension is possible under certain conditions.
How To YieldBoost Tutor Perini From 0.3% To 28.1% Using Options
This article explains how shareholders of Tutor Perini Corp (TPC) can potentially increase their income from a 0.3% annual dividend yield to 28.1% by selling July covered calls at the $90 strike price. This strategy, termed "YieldBoost," involves collecting a premium and assumes the stock is not called away. The article details the potential returns and risks of this options strategy, including historical volatility analysis.
Sharon AI Announces Nasdaq Listing and Pricing of $125 Million U.S. Initial Public Offering
Sharon AI, an Australian Neocloud company, has announced the pricing of its U.S. initial public offering (IPO) of 4,166,666 shares at $30.00 per share, raising approximately $125 million. The company's Class A Ordinary Common Stock is expected to begin trading on the Nasdaq Capital Market under the ticker symbol "SHAZ" on February 18, 2026. Proceeds from the offering will be used to acquire additional GPU-focused equipment and for general corporate purposes.
Averin Capital Acquisition Corp. (ACAAU) Prices $250M IPO
Averin Capital Acquisition Corp. (NASDAQ:ACAAU) has priced its $250 million IPO, with units expected to trade on the Nasdaq starting February 19, 2026. The SPAC aims to target a company within the technology and health sectors, led by CEO David A. Berry and CFO Alex Lau.
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026
Revolution Medicines (Nasdaq: RVMD) will announce its fourth quarter and full year 2025 financial results on February 25, 2026. The company will host a webcast at 4:30 p.m. ET to discuss these results and provide an update on its oncology pipeline, which includes clinical-stage RAS(ON) inhibitors like daraxonrasib and elironrasib.
Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering
Averin Capital Acquisition Corp. has priced its initial public offering of 25 million units at $10.00 per unit, appearing on the Nasdaq under the ticker symbol "ACAAU." The blank check company, led by CEO David A. Berry, intends to focus its acquisition search on the technology and health industries.
Ex-Dividend Reminder: HCI Group, Park National and Blue Owl Capital
HCI Group Inc (HCI), Park National Corp (PRK), and Blue Owl Capital Inc Class A (OWL) are set to trade ex-dividend on February 20, 2026. HCI will pay $0.40, PRK $1.10, and OWL $0.225. Investors should expect their share prices to open slightly lower on the ex-dividend date, reflecting the dividend payouts.
Canary debuts spot sui (SUI) exchange-traded fund with staking on the Nasdaq
Canary Capital has launched SUIS, the first spot Sui (SUI) exchange-traded fund (ETF) that incorporates staking rewards on the Nasdaq. This ETF provides investors with direct exposure to the price of Sui's native token and reflects net staking income in its net asset value, merging proof-of-stake rewards with traditional investment vehicles. The move signifies a growing trend of offering regulated ETF structures for newer layer-1 networks and gives investors access to Sui's performance and yield without direct management of crypto assets.
Baird Initiates Coverage of CSW Industrials (CSW) with Outperform Recommendation
Baird has initiated coverage of CSW Industrials (CSW) with an Outperform recommendation. Analysts project a 9.95% upside for the stock, with an average one-year price target of $323.34. The company is expected to see a 7.75% increase in annual revenue and funds show a bullish outlook on the stock.
Wells Fargo & Company $WFC Shares Sold by Advisors Capital Management LLC
Advisors Capital Management LLC significantly reduced its stake in Wells Fargo & Company ($WFC) by 18% in the third quarter of 2025, selling 130,900 shares and retaining 596,861 shares valued at approximately $50.03 million. Despite this, Wells Fargo exceeded recent EPS estimates with $1.76 versus $1.66, announced a $0.45 quarterly dividend, and holds a "Moderate Buy" consensus rating from analysts with an average price target of $97.03. Other institutional investors also adjusted their holdings, and the company's stock currently trades around $87.35 with a P/E of 13.93.
First spot SUI ETFs debut as Canary Capital and Grayscale launch funds with staking
Canary Capital and Grayscale have launched the first spot SUI exchange-traded funds (ETFs), offering investors direct exposure to the SUI token and staking rewards. Canary Capital's "Canary Stake SUI ETF" (SUIS) tracks the spot price of SUI on Nasdaq, while Grayscale converted its SUI trust into an ETF (GSUI) on NYSE Arca. These new ETFs provide a regulated way for investors to access the SUI ecosystem, which is built on the Layer 1 Sui blockchain developed by Mysten Labs.
Aether Holdings Issues Year-End Letter to Shareholders
Aether Holdings (NASDAQ: ATHR) issued its 2025 year-end Letter to Shareholders from Chairman Nicolas Lin, highlighting its mission to empower investors through educational content and professional-grade tools. The company detailed its progress in 2025, including its IPO, the formation of Alpha Edge Media, and several acquisitions to expand its offerings. Aether Holdings also outlined its strategic expansion in early 2026 with further acquisitions and the launch of SentimenTracker, aiming to diversify revenue and integrate its platforms into a cohesive fintech ecosystem.
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Marker Therapeutics (Nasdaq: MRKR) announced that CEO Dr. Juan Vera will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026. The presentation and subsequent investor meetings will focus on the company's progress with its Multi-Antigen Recognizing (MAR) T cell platform for treating hematological malignancies and solid tumors.
Currenc Group receives nasdaq compliance notice over delayed annual meeting
Currenc Group Inc. has received a Nasdaq compliance notice for failing to hold its annual shareholder meeting within the required timeframe. The company has scheduled a meeting for February 25, 2026, and is working with Nasdaq to address the issue. Despite this, the notice does not immediately impact the trading of Currenc's stock, which has seen significant declines recently.
Zscaler (ZS) Stock Dips While Market Gains: Key Facts
Zscaler (ZS) stock recently dipped by -2.88%, underperforming the broader market which saw slight gains for the S&P 500, Dow, and Nasdaq. The company's shares have fallen 16.95% over the last month, and investors are anticipating its upcoming earnings report on February 26, 2026, with projected EPS of $0.89 and revenue of $798 million. Zscaler currently holds a Zacks Rank of #4 (Sell) and a Forward P/E of 46.44, trading at a premium compared to its industry average.
Form 424B2 JPMORGAN CHASE & CO
JPMorgan Chase Financial Company LLC has filed a Form 424B2 with the SEC for Callable Contingent Interest Notes due February 22, 2030. These notes are linked to the performance of the Nasdaq-100 Index, Russell 2000 Index, and State Street Utilities Select Sector SPDR ETF, offering contingent interest payments if each underlying is above its interest barrier. The notes are unsecured obligations of JPMorgan Financial, guaranteed by JPMorgan Chase & Co., and involve risks including potential loss of principal and credit risk.
Form 424B2 CITIGROUP INC
Citigroup Global Markets Holdings Inc. is offering Autocallable Contingent Coupon Equity Linked Securities linked to the Nasdaq-100, Russell 2000, and S&P 500 Indexes, due August 16, 2027. These unsecured debt securities, guaranteed by Citigroup Inc., offer potential periodic contingent coupon payments but carry risks including possible loss of principal, no coupon payments, and early automatic redemption. Investors face heightened risks due to multiple underlying indexes and the credit risk of the issuer and guarantor.
May 2027 Options Now Available For monday.com
New May 2027 options for monday.com (MNDY) have begun trading, offering opportunities for investors due to the significant time value until expiration. Stock Options Channel identified a put contract at a $70.00 strike price and a call contract at a $95.00 strike price, both presenting potential YieldBoost returns for sellers. The article details the potential benefits for investors considering selling these options, including attractive entry points for stock purchases or enhanced returns through covered calls.
Nasdaq's DirectBooking to turn 16 shares into 1 to meet bid rule
DirectBooking Technology (Nasdaq: ZDAI) announced a 16-for-1 share consolidation, effective February 17, 2026, to comply with Nasdaq's minimum bid price requirement. Trading for the split-adjusted shares is expected to begin on February 19, 2026. The consolidation will not alter proportional ownership or the dual-class voting structure, and no fractional shares will be issued.
JFB and XTEND Announce $1.5B Business Combination to Establish a Nasdaq-Listed US Leader in AI-Driven Autonomous Defense Robotics
JFB Construction Holdings and XTEND have announced a $1.5 billion all-stock business combination to create XTEND AI Robotics, a Nasdaq-listed leader in AI-driven autonomous defense robotics. The new entity will combine XTEND's AI XTEND Operating System (XOS) with JFB's operational and infrastructure capabilities, aiming to strengthen US security and that of its allies. Strategic investors include Eric Trump and Unusual Machines, with the transaction expected to close in mid-2026.
